Intervention Review

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

  1. Andre D Sasse1,*,
  2. Emma C Sasse1,
  3. Luciana GO Clark2,
  4. Luciana Ulloa3,
  5. Otavio Augusto Camara Clark4

Editorial Group: Cochrane Skin Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 14 NOV 2006

DOI: 10.1002/14651858.CD005413.pub2

How to Cite

Sasse AD, Sasse EC, Clark LGO, Ulloa L, Clark OAC. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005413. DOI: 10.1002/14651858.CD005413.pub2.

Author Information

  1. 1

    Campinas, Sao Paulo, Brazil

  2. 2

    Hospital Celso Pierro/PUC-Campinas e Instituto do Radium de Campinas, Oncology, Campinas, São Paulo, Brazil

  3. 3

    Public Health Unit, Blumenau-SC, Brazil

  4. 4

    Hospital e Maternidade Celso Pierro/PUC-Campinas e Instituto do Radium de Campinas, Campinas, San Paolo, Brazil

*Andre D Sasse, Av Dr. Luiz de Tella 1515, Cidade Universitaria, Campinas, Sao Paulo, 13083 000, Brazil. andre@sasse.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

    Andre D Sasse, Emma C Sasse, Luciana GO Clark, Luciana Ulloa and Otavio Augusto Camara Clark

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD005413.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

    AD Sasse, EC Sasse, LGO Clark, L Ulloa and OAC Clark

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD005413